90
Views
1
CrossRef citations to date
0
Altmetric
Articles

Micro-brushing-based technique to gain fresh urothelial cells for gene expression analysis

, , , , , , & show all

References

  • Barr-Fritcher, E. G., Voss, J. S., Brankley, S. M., Campion, M. B., Jenkins, S. M., Keeney, M. E., Henry, M. R., Kerr, S. M., Chaiteerakij, R., Pestova, E. V., Clayton, A. C., Zhang, J., Roberts, L. R., Gores, G. J., Halling, K. C., and Kipp, B. R. 2015. An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples. Gastroenterology 149: 1813–1824.
  • Catto, J. W., Yates, D. R., Rehman, I., Azzouzi, A. R., Patterson, J., Sibony, M., Cussenot, O., and Hamdy, F. C. 2007. Behavior of urothelial carcinoma with respect to anatomical location. J. Urol. 77: 1715–1720.
  • Crivelli, J. J., Xylinas, E., Kluth, L. A., Rieken, M., Rink, M., and Shariat, S. F. 2014. Effect of smoking on outcomes of urothelial carcinoma: A systematic review of the literature. Eur. Urol. 65: 742–754.
  • Dodd, L. G., Johnston, W. W., Robertson, C. N., and Layfield, L. J. 1997. Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis. Acta Cytol. 41: 377–384.
  • Flieger, A., Golka, K., Schulze, H., and Follmann, W. 2008. Primary cultures of human urothelial cells for genotoxicity testing. J. Toxicol. Environ. Health A 71: 930–935.
  • González-Peramato, P., Jiménez-Heffernan, J. A., García-González, R., and García-Navas, R. 2004. Urinary cytology in the diagnosis of upper urinary tract urothelial tumor. Arch. Esp. Urol. 57: 227–238. (in Spanish).
  • Grotenhuis, A. J., Dudek, A. M., Verhaegh, G. W., Witjes, J. A., Aben, K. K., Van Der Marel, S. L., Vermeulen, S. H., and Kiemeney, L. A. 2014. Prognostic relevance of urinary bladder cancer susceptibility loci. Plos One 9: e89164.
  • Hofstädter, F. 2009. Renal pelvic carcinoma: A different urothelial tumor? Pathologe 30 Suppl 2: 185–187. (in German).
  • Kempkes, M., Golka, K., Reich, S., Reckwitz, T., and Bolt, H. M. 1996. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch. Toxicol. 71: 123–126.
  • Kiemeney, L. A., Thorlacius, S., Sulem, P., Geller, F., Aben, K. K., Stacey, S. N., Gudmundsson, J., Jakobsdottir, M., Bergthorsson, J. T., Sigurdsson, A., Blondal, T., Witjes, J. A., Vermeulen, S. H., Hulsbergen-Van De Kaa, C. A., Swinkels, D. W., Ploeg, M., Cornel, E. B., Vergunst, H., Thorgeirsson, T. E., Gudbjartsson, D., Gudjonsson, S. A., Thorleifsson, G., Kristinsson, K. T., Mouy, M., Snorradottir, S., Placidi, D., Campagna, M., Arici, C., Koppova, K., Gurzau, E., Rudnai, P., Kellen, E., Polidoro, P., Guarrera, S., Sacerdote, C., Sanchez, M., Saez, B., Valdivia, G., Ryk, C., De Verdier, P., Lindblom, A., Golka, K., Bishop, D. T., Knowles, M. A., Nikulasson, S., Petursdottir, V., Jonsson, E., Geirsson, G., Kristjansson, B., Mayordomo, J. I., Steineck, G., Porru, S., Buntinx, F., Zeegers, M. P., Fletcher, T., Kumar, R., Matullo, G., Vineis, P., Kiltie, A. E., Gulcher, J. R., Thorsteinsdottir, U., Kong, A., Rafnar, T., and Stefansson, K. 2008. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40: 1307–1312.
  • Lerner, S. P., McConkey, D. J., Hoadley, K. A., Chan, K. S., Kim, W. Y., Radvanyi, F., Höglund, M., and Real, F. X. 2016. Bladder cancer molecular taxonomy: Summary from a consensus meeting. Bl. Cancer 2: 37–47.
  • Li, Q., Bagrodia, A., Cha, E. K., and Coleman, J. A. 2016. Prognostic genetic signatures in upper tract urothelial carcinoma. Curr. Urol. Rep. 17: 12.
  • Muniraj, F., Siddaraju, N., and Sistla, S. C. 2016. Role of brush cytology in the diagnosis of neoplastic and non-neoplastic upper gastrointestinal lesions. Cytopathology 27: 407–417.
  • Qiagen QuantiTect-Whole-Transcriptome-Handbook. July 2011. https://www.qiagen.com/de/resources/resourcedetail?id=6910f167-e4ae-43a2-b87d-26a74c55a75c ( accessed July 4 2016).
  • Qiagen RNAlater Handbook RNAlater RNA Stabilization Reagent. July 2006. https://www.qiagen.com/de/resources/resourcedetail?id=38566945-e96b-46a4-a287-ec026849da4b&lang=en ( accessed July 4 2016).
  • Qiagen RNeasy® Micro Handbook. December 2014. https://www.qiagen.com/de/resources/resourcedetail?id=14e7cf6e-521a-4cf7-8cbc-bf9f6fa33e24&lang=en ( accessed July 4 2016).
  • Rink, M., Furberg, H., Zabor, E. C., Xylinas, E., Babjuk, M., Pycha, A., Lotan, Y., Karakiewicz, P. I., Novara, G., Robinson, B. D., Montorsi, F., Chun, F. K., Scherr, D. S., and Shariat, S. F. 2013. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur. Urol. 63: 724–732.
  • Rolls, G. 2016. An Introduction to Specimen Processing. http://www.leicabiosystems.com/pathologyleaders/an-introduction-to-specimen-processing/( accessed July 4 2016).
  • Roth, E., Selinski, S., Schikowsky, C., Seidel, T., Volkert, F., Blaszkewicz, M., Hengstler, J. G., and Golka, K. 2012. Bladder cancer survival in a former industrial area in Saxony-Anhalt, Germany. J. Toxicol. Environ. Health A 75: 1216–1225.
  • Rouprêt, M., Drouin, S. J., Cancel-Tassin, G., Comperat, E., Larré, S., and Cussenot, O. 2012. Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis. J. Urol. 187: 424–428.
  • Schnippel, K., Michelow, P., Chibwesha, C. J., Makura, C., Lince-Deroche, N., Goeieman, B., Mulongo, M., Jordaan, S., and Firnhaber, C. 2015. Cost-effectiveness of using the cervex-brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: A model-based analysis. BMC Health Serv. Res. 15: 499.
  • Selinski, S., Bürger, H., Blaszkewicz, M., Otto, T., Volkert, F., Moormann, O., Niedner, H., Hengstler, J. G., and Golka, K. 2016. Occupational risk factors for relapse-free survival in bladder cancer patients. J. Toxicol. Environ. Health A 79: 1136–1143.
  • Skipworth, J. R., Timms, J. F., and Pereira, S. P. 2013. Novel diagnostic and prognostic biomarkers in biliary tract cancer. Expert Opin. Med. Diagn. 7: 487–499.
  • Whitaker, C. J., Stamp, E. C., Young, W., and Greenwood, L. 2009. A comparison of the efficacy of the cervex brush and the extended-tip wooden spatula with conventional cytology: A longitudinal study. CytoJournal 6: 2.
  • Yates, D. R., and Catto, J. W. 2013. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: How molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours. World J. Urol. 31: 21–29.
  • Ye, X., Prieto, D. A., Chan, K. C., Wei, B. R., and Blonder, J. 2013. “Tissue sample preparation for proteomic analysis.” Proteomic and Metabolomics Approaches to Biomarker Discovery, edited by H. J. Issaq and T. D. Veenstra, 40–51. London: Academic Press.
  • Zhang, Z., Furge, K. A., Yang, X. J., Teh, B. T., and Hansel, D. E. 2010. Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med. Genomics 3: 58.
  • Zylka-Menhorn, V., and Siegmund-Schultze, N. 2010. 29. Deutscher Krebskongress: Molekularbiologische Wissensexplosion. Dtsch. Ärztbl. 207 C: 328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.